• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

BriaCell Therapeutics Corp

+ Add to Watchlist

ANCCF:US

0.1560 USD 0.0069 4.24%

As of 20:10:03 ET on 01/23/2015.

Snapshot for BriaCell Therapeutics Corp (ANCCF)

Open: 0.1560 Day's Range: 0.1560 - 0.1560 Volume: 2,500
Previous Close: 0.1629 52wk Range: 0.1245 - 0.2730 1-Yr Rtn: -

Stock Chart for ANCCF

No chart data available.
  • ANCCF:US 0.1560
  • 1D
  • 1M
  • 1Y
0.1629
Interactive ANCCF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ANCCF

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 13.14
Shares Outstanding (M) 84.21
30 Day Average Volume 4,527
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ANCCF

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for ANCCF

BriaCell Therapeutics Corp. operates as a breast cancer immunotherapy biotech research and developer. The Company developed a patented whole-cell vaccine, cancer immunotherapy technology called the "BriaVax" vaccine. BriaCell has offices in North America.

Charles L WisemanChairman/CEORahoul SharanChief Financial Officer
Senthamil SelvanPrincipal ScientistSteven J O'DayPrincipal Investigator
More Company Profile & Key Executives for ANCCF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil